Unprovoked recurrent venous thrombosis: prediction by D-dimer and clinical risk factors

被引:47
作者
Baglin, T. [1 ]
Palmer, C. R. [2 ]
Luddington, R. [1 ]
Baglin, C. [1 ]
机构
[1] Univ Cambridge, Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England
[2] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Appl Med Stat, Cambridge, England
关键词
D-dimer; deep vein thrombosis; pulmonary embolus; recurrence; thrombosis;
D O I
10.1111/j.1538-7836.2008.02889.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aim of the study was to determine the predictive value of D-dimer measurement for unprovoked recurrent venous thrombosis and the influence of sex, age and type of first event (unprovoked or provoked). Methods: Prospective cohort study of 272 patients with a first episode of venous thrombosis that was unprovoked or provoked by a non-surgical trigger. Findings: The cumulative rate of unprovoked recurrence in patients with a positive D-dimer was 20% at 5 years [5.5/100 patient-years, 95% confidence interval (CI) 3.7-7.8] and in patients with a negative D-dimer 17% (4.1/100 patient-years, 95% CI 2.3-6.9). The rates are not different (hazard ratio 1.3, 95% CI 0.7-2.5). After adjustment for clinical risk factors a positive D-dimer result was significantly associated with an increased risk of unprovoked recurrent thrombosis (hazard ratio 2.0, 95% CI 1.01-3.9). The strongest indicator of risk of recurrence was male sex (hazard ratio 3.3 unadjusted and 2.9 after adjustment). The only determinant of D-dimer in a linear regression model was age (P < 0.001). Conclusions: The analysis indicates that clinical risk factors confound the association between D-dimer and risk of recurrence and when adjusted for these confounders a positive D-dimer result is significantly associated with unprovoked recurrence. The clinical utility of D-dimer measurement in individual patients should be interpreted in conjunction with clinical risk factors.
引用
收藏
页码:577 / 582
页数:6
相关论文
共 18 条
  • [1] Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: not yet
    Baglin, T.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (12) : 2530 - 2532
  • [2] Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study
    Baglin, T
    Luddington, R
    Brown, K
    Baglin, C
    [J]. LANCET, 2003, 362 (9383) : 523 - 526
  • [3] STATISTICAL-METHODS FOR CLINICAL-TRIALS
    BAILEY, A
    CROOK, A
    MACHIN, D
    [J]. BLOOD REVIEWS, 1994, 8 (02) : 105 - 112
  • [4] Brito-Babapulle V, 1998, BRIT J HAEMATOL, V101, P43
  • [5] Antithrombotic therapy for venous thromboembolic disease
    Büller, HR
    Agnelli, G
    Hull, RD
    Hyers, TA
    Prins, AH
    Raskob, GE
    [J]. CHEST, 2004, 126 (03) : 401S - 428S
  • [6] Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: yes
    Cosmi, B.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (12) : 2527 - 2529
  • [7] Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
    Douketis, JD
    Kearon, C
    Bates, S
    Duku, EK
    Ginsberg, JS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06): : 458 - 462
  • [8] D-dimer levels and risk of recurrent venous thromboembolism
    Eichinger, S
    Minar, E
    Bialonczyk, C
    Hirschl, M
    Quehenberger, P
    Schneider, B
    Weltermann, A
    Wagner, O
    Kyrle, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (08): : 1071 - 1074
  • [9] The post-thrombotic syndrome: current knowledge, controversies, and directions for future research
    Kahn, SR
    Ginsberg, JS
    [J]. BLOOD REVIEWS, 2002, 16 (03) : 155 - 165
  • [10] Natural history of venous thromboembolism
    Kearon, C
    [J]. CIRCULATION, 2003, 107 : I22 - I30